Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) For research use only.
Not for use in humans.

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Synonyms: VIS649

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.

Product Details

CAS No. 2382896-07-1
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) | Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) supplier | purchase Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) | Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) cost | Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) manufacturer | order Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) | Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) distributor